Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Latest Attention Deficit Hyperactivity Disorder (ADHD) News and Research

New understanding of drug addiction

The reason why some individuals may be predisposed to drug addiction has been discovered by scientists from the universities of Bristol and Cambridge.

1 Mar 2007

Simple eye movement test spots fetal alcohol spectrum disorders

Canadian researchers have found that simple eye movement tests can effectively diagnose fetal alcohol spectrum disorders (FASD) in children.

26 Feb 2007

FDA wants clear warnings on ADHD drugs

The Food and Drug Administration (FDA) in the United States has ordered drugmakers to alert patients to the possible cardiovascular and psychiatric risks attached to drugs used to treat attention deficit hyperactivity disorder (ADHD).

22 Feb 2007

Swedish brain researchers gain access to unique IBM supercomputer

Approximately 127 million people in Europe are suffering from some kind of brain disease or injury. With the long term goal to improve diagnostics and find new therapies in their sights, the Stockholm Brain Institute (SBI) and IBM have embarked on a partnership that gives Swedish brain researchers access to a unique supercomputer.

21 Feb 2007

High dopamine transporter levels not linked to attention-deficit hyperactivity disorder

Results from a brain-imaging study conducted at the U.S. Department of Energy's Brookhaven National Laboratory in collaboration with Mount Sinai School of Medicine in New York indicate that levels of a brain protein proposed as a diagnostic marker for attention-deficit hyperactivity disorder (ADHD) are not positively correlated with the disease.

2 Dec 2006

Toxic chemicals affecting childrens brains

According to a new report toxic chemicals may be causing a pandemic of brain disorders because of inadequate regulation.

8 Nov 2006

UIC study evaluates two medications for ADHD

University of Illinois at Chicago researchers are comparing two drugs commonly used to treat attention deficit hyperactivity disorder to determine if genetic factors predict which children will respond to either or both drugs.

7 Nov 2006

Popular ADHD drug Ritalin safe and effective for pre-schoolers

A new study by researchers from the Johns Hopkins Children's Center and five other medical centers concludes that carefully measured, low doses of methylphenidate (Ritalin) are safe and effective for attention-deficit and hyperactivity disorder (ADHD) in preschoolers.

23 Oct 2006

Parents too often unaware of child's drug abuse

According to the latest research parents do not provide valuable information about their children's use of alcohol and drugs because they are often unaware of it; and this is true of even the most observant parents, with the most open family relationships who are often oblivious to their children's use and abuse of alcohol, cigarettes and drugs.

25 Sep 2006

More physicians now visit web sites to find information on brand-name prescription drugs

An increased number of physicians visited Web sites that promote brand-name prescription drugs during the first six months of 2006 to seek information about dosages and side effects, according to a recent Manhattan Research study, the Newark Star-Ledger reports.

18 Sep 2006

ADHD drugs to carry warnings regarding heart problems, psychotic behavior and sudden death

According to U.S. health officials several drugs used to treat attention deficit hyperactivity disorder (ADHD) must now include new warning information about the risk of serious heart problems, psychotic behavior and sudden death.

24 Aug 2006

Boston Life Sciences announces issuance of U.S. patent for methods to diagnose ADHD

Boston Life Sciences has announced that the U.S. Patent and Trademark Office has issued a patent to the President and Fellows of Harvard College, the General Hospital Corporation and Organix that covers methods of diagnosing and monitoring attention deficit hyperactivity disorder (ADHD) by assessing the level of dopamine transporter (DAT) in at least one region of a patient's central nervous system.

14 Aug 2006

Almost half of kids with ADHD are not being treated

In contrast to claims that children are being overmedicated for attention-deficit/hyperactivity disorder (ADHD), a team of researchers at Washington University School of Medicine in St. Louis has found that a high percentage of kids with ADHD are not receiving treatment.

4 Aug 2006

Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Latest Attention Deficit Hyperactivity Disorder (ADHD) News and Research

New understanding of drug addiction

Simple eye movement test spots fetal alcohol spectrum disorders

FDA wants clear warnings on ADHD drugs

Swedish brain researchers gain access to unique IBM supercomputer

High dopamine transporter levels not linked to attention-deficit hyperactivity disorder

Toxic chemicals affecting childrens brains

UIC study evaluates two medications for ADHD

Popular ADHD drug Ritalin safe and effective for pre-schoolers

Parents too often unaware of child's drug abuse

More physicians now visit web sites to find information on brand-name prescription drugs

ADHD drugs to carry warnings regarding heart problems, psychotic behavior and sudden death

Boston Life Sciences announces issuance of U.S. patent for methods to diagnose ADHD

Almost half of kids with ADHD are not being treated

Treatment for ADHD: Is more complex treatment cost-effective for more complex cases?

Research shows which sex differences are developmental vs. sociological vs. hormonal

"Magic" mushrooms create profound mystical experience and change behaviour

Study shows how ADHD drugs Adderall, Ritalin and Dexedrine work in brain

Dancing helps boys with ADHD

Midbrain, striatal and amygdalar dopaminergic dysfunction in ADHD

Misuse of ADHD drugs sends thousands each year to seek emergency hospital treatment

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Latest Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in